
2021 Course on targeting mutant HTT therapeutically for clinicians of the movement disorder society (MDS) by Ignacio Munoz-Sanjuan
In this 2021 course, Dr. Ignacio Munoz-Sanjuan, VP of translational biology at CHDI Foundation, speaks to the clinicians and movement disorder residents as part of